Home LiteratureArticle Details
PMID: 14722302 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection.

Journal of virology ·Vol. 78 ·No. 3 ·2004-02-00 ·Pages 1464-72

Bostik P, Dodd GL, Villinger F, Mayne AE, Ansari AA

Abstract

CD4(+) T-cell dysfunction highlighted by defects within the intracellular signaling cascade and cell cycle has long been characterized as a direct and/or indirect consequence of human immunodeficiency virus (HIV) infection in humans and simian immunodeficiency virus (SIV) infection in rhesus macaques (RM). Dysregulation of the M phase of the cell cycle is a well-documented effect of HIV or SIV infection both in vivo and in vitro. In this study the effect of SIV infection on the modulation of two important regulators of the M phase-polo-like kinases Plk3 and Plk1-was investigated. We have previously shown that Plk3 is markedly downregulated in CD4(+) T cells from SIV-infected disease-susceptible RM but not SIV-infected disease-resistant sooty mangabeys (SM), denoting an association of downregulation with disease progression. Here we show that, in addition to the downregulation, Plk3 exhibits aberrant activation patterns in the CD4(+) T cells from SIV-infected RM following T-cell receptor stimulation. Interestingly, in vitro SIV infection of CD4(+) T cells leads to the upregulation, rather than downregulation, of Plk3, suggesting that different mechanisms operate in vitro and in vivo. In addition, CD4(+) T cells from RM with high viral loads exhibited consistent and significant upregulation of Plk1, concurrent with an aberrant activation-induced Plk1 response, suggesting complex mechanisms of SIV-induced M-phase abnormalities in vivo. Altogether this study presents a novel mechanism underlying M-phase defects observed in CD4(+) T cells from HIV or SIV-infected disease-susceptible humans and RM which may contribute to aberrant T-cell responses and disease pathogenesis.

MeSH Terms
Animals CD4-Positive T-Lymphocytes/enzymology,pathology,virology Cell Cycle Proteins/metabolism Cell Line, Transformed Cells, Cultured Cercocebus atys Down-Regulation Humans Lymphocyte Activation Macaca mulatta Mitosis Protein Kinases/metabolism Protein Serine-Threonine Kinases/metabolism Proto-Oncogene Proteins Simian Acquired Immunodeficiency Syndrome/physiopathology,virology Simian Immunodeficiency Virus/pathogenicity Tumor Suppressor Proteins Up-Regulation
Chemicals
Cell Cycle Proteins Proto-Oncogene Proteins Tumor Suppressor Proteins Protein Kinases PLK3 protein, human Protein Serine-Threonine Kinases polo-like kinase 1
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bostik Pavel
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA. pbostik@emory.edu
Dodd Geraldine L
Villinger Francois
Mayne Ann E
Ansari Aftab A
References (53)
53 references, click to expand
  1. The physical association and phosphorylation of Cdc25C protein phosphatase by Prk.
    Oncogene. 1999 Oct 28;18(44):6029-36 PMID: 10557092
  2. Cell cycle regulation of the human polo-like kinase (PLK) promoter.
    J Biol Chem. 1997 Apr 4;272(14):9166-74 PMID: 9083047
  3. PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer.
    Genes Chromosomes Cancer. 2000 Mar;27(3):332-6 PMID: 10679924
  4. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.
    J Virol. 2000 Jul;74(13):5747-53 PMID: 10846052
  5. Inverse correlation of telomerase activity/proliferation of CD4+ T lymphocytes and disease progression in simian immunodeficiency virus-infected nonhuman primates.
    J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):89-99 PMID: 10935683
  6. Polo-like kinase-1 is a target of the DNA damage checkpoint.
    Nat Cell Biol. 2000 Sep;2(9):672-6 PMID: 10980711
  7. Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages.
    Oncogene. 2000 Oct 5;19(42):4832-9 PMID: 11039900
  8. The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase.
    Cell Signal. 2000 Jun;12(6):405-11 PMID: 11202906
  9. Relative resistance in the development of T cell anergy in CD4+ T cells from simian immunodeficiency virus disease-resistant sooty mangabeys.
    J Immunol. 2001 Jan 1;166(1):506-16 PMID: 11123330
  10. Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis.
    Blood. 2001 Mar 15;97(6):1756-64 PMID: 11238118
  11. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.
    Nature. 2001 Mar 8;410(6825):215-20 PMID: 11242082
  12. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.
    Nat Med. 1998 Jan;4(1):65-71 PMID: 9427608
  13. HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3419-24 PMID: 9520381
  14. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents.
    Science. 1998 Jul 10;281(5374):266-9 PMID: 9657723
  15. PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression.
    Mol Cell. 1998 Feb;1(3):371-80 PMID: 9660921
  16. Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progression.
    Biochem J. 1998 Aug 1;333 ( Pt 3):655-60 PMID: 9677325
  17. Development of an animal model for autotransfusion therapy: in vitro characterization and analysis of anti-CD3/CD28 expanded cells.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1;19(3):210-20 PMID: 9803962
  18. Ubiquitination and proteasome mediated degradation of polo-like kinase.
    Biochem Biophys Res Commun. 1998 Nov 18;252(2):340-4 PMID: 9826531
  19. Polo-like kinases: a team that plays throughout mitosis.
    Genes Dev. 1998 Dec 15;12(24):3777-87 PMID: 9869630
  20. Polo-like kinases: positive regulators of cell division from start to finish.
    Curr Opin Cell Biol. 1998 Dec;10(6):776-83 PMID: 9914175
  21. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.
    Annu Rev Immunol. 1999;17:625-56 PMID: 10358770
  22. Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients.
    AIDS. 1999 Jul 9;13(10):1159-64 PMID: 10416518
  23. Molecular interaction map of the mammalian cell cycle control and DNA repair systems.
    Mol Biol Cell. 1999 Aug;10(8):2703-34 PMID: 10436023
  24. The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and integrin-binding protein and are regulated dynamically with synaptic plasticity.
    EMBO J. 1999 Oct 15;18(20):5528-39 PMID: 10523297
  25. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25.
    Virology. 2001 Sep 1;287(2):359-70 PMID: 11531413
  26. Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3.
    J Biol Chem. 2001 Sep 28;276(39):36194-9 PMID: 11447225
  27. Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals.
    J Virol. 2001 Nov;75(22):10843-55 PMID: 11602725
  28. Identification of protein kinases dysregulated in CD4(+) T cells in pathogenic versus apathogenic simian immunodeficiency virus infection.
    J Virol. 2001 Dec;75(23):11298-306 PMID: 11689610
  29. Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway.
    J Biol Chem. 2001 Nov 16;276(46):43305-12 PMID: 11551930
  30. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors.
    Int J Oncol. 2002 Jan;20(1):121-6 PMID: 11743651
  31. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.
    J Cell Biol. 2002 Jan 21;156(2):249-59 PMID: 11807090
  32. Plk1 promotes nuclear translocation of human Cdc25C during prophase.
    EMBO Rep. 2002 Apr;3(4):341-8 PMID: 11897663
  33. Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA.
    Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8672-6 PMID: 12077309
  34. Abrogation of the S phase DNA damage checkpoint results in S phase progression or premature mitosis depending on the concentration of 7-hydroxystaurosporine and the kinetics of Cdc25C activation.
    J Biol Chem. 2002 Jul 19;277(29):26553-64 PMID: 11953432
  35. Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis.
    J Virol. 2003 Feb;77(3):2063-70 PMID: 12525641
  36. Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion.
    AIDS. 1990 Jan;4(1):77-81 PMID: 1969282
  37. CD4 and CD8 T cells from SIV-infected macaques have defective signaling responses after perturbation of either CD3 or CD2 receptors.
    Int Immunol. 1990;2(9):849-58 PMID: 1980619
  38. Stable growth transformation of human T lymphocytes by herpesvirus saimiri.
    Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3116-9 PMID: 1313581
  39. Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis.
    J Clin Immunol. 1992 May;12(3):216-24 PMID: 1383258
  40. Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors.
    Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1736-40 PMID: 8127874
  41. Identification by targeted differential display of an immediate early gene encoding a putative serine/threonine kinase.
    J Biol Chem. 1995 Apr 28;270(17):10351-7 PMID: 7730342
  42. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.
    J Virol. 1995 Oct;69(10):6304-13 PMID: 7666531
  43. HIV accessory proteins as therapeutic targets.
    Nat Med. 1997 Apr;3(4):389-94 PMID: 9095171
  44. Downregulation of polo-like kinase correlates with loss of proliferative ability of cardiac myocytes.
    J Mol Cell Cardiol. 1997 Mar;29(3):929-37 PMID: 9152854
  45. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest.
    J Virol. 1997 Jul;71(7):5579-92 PMID: 9188632
  46. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.
    Science. 1997 Sep 5;277(5331):1501-5 PMID: 9278512
  47. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.
    J Virol. 1995 Nov;69(11):6705-11 PMID: 7474080
  48. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.
    J Virol. 1995 Nov;69(11):6859-64 PMID: 7474100
  49. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.
    J Virol. 1996 Apr;70(4):2324-31 PMID: 8642659
  50. Prk, a cytokine-inducible human protein serine/threonine kinase whose expression appears to be down-regulated in lung carcinomas.
    J Biol Chem. 1996 Aug 9;271(32):19402-8 PMID: 8702627
  51. HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.
    J Clin Invest. 1996 Sep 15;98(6):1290-7 PMID: 8823293
  52. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM).
    EMBO J. 1996 Nov 15;15(22):6155-65 PMID: 8947037
  53. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection.
    J Virol. 2000 Feb;74(3):1209-23 PMID: 10627531
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-02-00
Pages
1464-72
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC321363
Subset
IM
Grants
NIAID NIH HHS · R01 AI051994 · United States
NIAID NIH HHS · R01 AI51994 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com